227 results

scale2
Access Value

Posted on 01.06.2010

The real worth of medical technologies

The blogosphere has been driven into a foment over the last week or so by a paper by Groeneveld et al entitled ‘Increasing Use of Cardiovascular Devices and Rising Health Costs’. Its conclusions are interesting but, I suggest, not conclusive of anything which should prompt policy makers to ask further questions. Discounted for inflation the […]

By John Wilkinson Former Chief Executive of Eucomed

traveler
Business Global

Posted on 20.04.2010

Musings on markets from weary traveller

Like much of the business community I have had plenty of time for thought and reading. A 24 hour trip to Milan has turned into a five day marathon. Both reading and experience have stimulated thoughts about the operation of markets. Firstly, after several hours on Thursday, I managed to secure a hotel room in […]

By John Wilkinson Former Chief Executive of Eucomed

corrupt
Ethics Global

Posted on 29.03.2010

Is corruption an ethnocentric concept? My first experience as a guest lecturer

Talking about ethics and compliance as industry understands it within the frame of a course of Health Systems Management given at the Public Health School of the Université Libre de Bruxelles (ULB) presented itself as a challenge. On the one hand, Eucomed is putting a lot of efforts into promoting a culture of integrity and […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

kidneyday2
Global

Posted on 11.03.2010

Today is World Kidney Day

The prominence of World Kidney Day (11th March) brings into sharp focus the changing epidemiology of our times and the impact of modern life styles of the developed world on the demands placed on healthcare systems. The surge in incidence of diabetes coupled with extending life expectancy are producing a parallel rise in the incidence […]

By John Wilkinson Former Chief Executive of Eucomed

outsource
Business Global

Posted on 23.02.2010

Outsourcing R&D and the Medtech industry

In recent weeks within the pharmaceutical industry there has been much talk of both downsizing – GSK and AstraZeneca shedding 11,000 jobs – and outsourcing of research and development, with a whole range of licensing or partnership deals designed to pad out faltering product pipelines. Once again I was prompted to think about the prospect […]

By John Wilkinson Former Chief Executive of Eucomed

press
Global

Posted on 12.02.2010

Clinton brings stents into the news

It is perhaps surprising how quickly coronary angioplasty has become just another everyday procedure. As someone who has seen open-heart surgery live and witnessed the trauma and hospital resource intensity of such procedures, the placing of a stent as an alternative is almost unimaginably better for both patient and the health sytem as a whole. […]

By John Wilkinson Former Chief Executive of Eucomed

late-payment
Global

Posted on 16.12.2009

Avoiding repeats of the ‘Greek Tragedy’

As the true depth of the Greek debt crisis unfolds it is hard to understand why the alarm bells were not ringing long ago. In our sector alone there is something in the region of €2.3 billion of unpaid bills and this has not happened overnight. We were warning of this particular symptom almost two […]

By John Wilkinson Former Chief Executive of Eucomed

global-harmony
Global Regulation

Posted on 11.12.2009

An opportunity for true global harmonisation?

In an ideal world we would have the same rules on devices in each country.  As patients, as we live or travel in different countries, we can be confident that should we fall ill, the devices used to help us are as safe as the ones at home.  As businesses, we would be confident that […]

By John Brennan Director Regulations and Industrial Policy

advamed2009
Value

Posted on 14.10.2009

John Wilkinson at AdvaMed 2009: A view on the US health reforms

A chill wind is blowing through Washington D.C. this morning and it is not just the cold front from the North blowing away the warm Autumn sun of yesterday. Yesterday, the Obama health reforms took their first step on a long and perilous road through the legislature when the Senate Finance Committee passed the preliminary […]

By John Wilkinson Former Chief Executive of Eucomed